A Study of KW-6356 in Subjects With Early Parkinson's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 22, 2017

Study Completion Date

December 8, 2017

Conditions

Parkinson's Disease

Interventions

DRUG

KW-6356

Oral administration

DRUG

KW-6356

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (7)

Asahikawa

Akashi

Fujisawa

Suita

Nakano City

Setagaya City

Kyoto

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02939391 - A Study of KW-6356 in Subjects With Early Parkinson's Disease | Biotech Hunter | Biotech Hunter